Literature DB >> 15221779

Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia-reperfusion injury: functional proteomics studies.

Grzegorz Sawicki1, Bodh I Jugdutt.   

Abstract

In this study, we demonstrate the use of proteomics to detect regional differences in protein levels between the reperfused ischemic zone (IZ) and the nonischemic zone (NIZ) of dog hearts which were subjected to in vivo ischemia-reperfusion injury. Using the two-dimensional gel electrophoresis (2-DE) technique, we identified five proteins that were differentially expressed in the IZ versus NIZ: (1) the alpha subunit of ATP synthase isoform precursor was decreased 1.71-fold; (2) creatine kinase M chain was decreased 1.72-fold; (3) NAD+-isocitrate dehydrogenase, alpha subunit was increased 8.34-fold; (4) ATP synthase D chain, mitochondrial was increased 3.02-fold; (5) ventricular myosin light chain-1 was decreased 2.02-fold. Additionally, we found that the level of actin was decreased 2.6-times in the IZ compared to the NIZ on Western blot analysis but was unchanged on 2-DE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221779     DOI: 10.1002/pmic.200300746

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  15 in total

1.  Integrated Omic Analysis of a Guinea Pig Model of Heart Failure and Sudden Cardiac Death.

Authors:  D Brian Foster; Ting Liu; Kai Kammers; Robert O'Meally; Ni Yang; Kyriakos N Papanicolaou; C Conover Talbot; Robert N Cole; Brian O'Rourke
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

Review 2.  Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine.

Authors:  Maral Ouzounian; Douglas S Lee; Anthony O Gramolini; Andrew Emili; Masahiro Fukuoka; Peter P Liu
Journal:  Can J Cardiol       Date:  2007-08       Impact factor: 5.223

3.  The new biology: a bridge to clinical cardiology.

Authors:  Ge Louridas; Kg Lourida
Journal:  Hippokratia       Date:  2012-04       Impact factor: 0.471

4.  Role of healing-specific-matricellular proteins and matrix metalloproteinases in age-related enhanced early remodeling after reperfused STEMI in dogs.

Authors:  Bodh I Jugdutt; Arivazhagan Palaniyappan; Richard R E Uwiera; Halliday Idikio
Journal:  Mol Cell Biochem       Date:  2008-11-05       Impact factor: 3.396

5.  Effects of MMP-9 inhibition by doxycycline on proteome of lungs in high tidal volume mechanical ventilation-induced acute lung injury.

Authors:  Adrian Doroszko; Thomas S Hurst; Dorota Polewicz; Jolanta Sawicka; Justyna Fert-Bober; David H Johnson; Grzegorz Sawicki
Journal:  Proteome Sci       Date:  2010-01-29       Impact factor: 2.480

6.  Ischemia induced peroxynitrite dependent modifications of cardiomyocyte MLC1 increases its degradation by MMP-2 leading to contractile dysfunction.

Authors:  Dorota Polewicz; Virgilio J J Cadete; Adrian Doroszko; Beth E Hunter; Jolanta Sawicka; Danuta Szczesna-Cordary; Peter E Light; Grzegorz Sawicki
Journal:  J Cell Mol Med       Date:  2010-05-26       Impact factor: 5.310

7.  Proteomic analysis of cardiac metabolic enzymes in asphyxiated newborn piglets.

Authors:  Justyna Fert-Bober; Grzegorz Sawicki; Gary D Lopaschuk; Po-Yin Cheung
Journal:  Mol Cell Biochem       Date:  2008-07-08       Impact factor: 3.396

8.  Novel O-palmitolylated beta-E1 subunit of pyruvate dehydrogenase is phosphorylated during ischemia/reperfusion injury.

Authors:  Clifford Dl Folmes; Grzegorz Sawicki; Virgilio Jj Cadete; Grant Masson; Amy J Barr; Gary D Lopaschuk
Journal:  Proteome Sci       Date:  2010-07-09       Impact factor: 2.480

9.  DIGE proteome analysis reveals suitability of ischemic cardiac in vitro model for studying cellular response to acute ischemia and regeneration.

Authors:  Sina Haas; Heinz-Georg Jahnke; Nora Moerbt; Martin von Bergen; Seyedhossein Aharinejad; Olena Andrukhova; Andrea A Robitzki
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 10.  Valsartan in the treatment of heart attack survivors.

Authors:  Bodh I Jugdutt
Journal:  Vasc Health Risk Manag       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.